...
首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Endovascular Treatment of 147 Cases of Cavernous Carotid Aneurysms: A Single-Center Experience
【24h】

Endovascular Treatment of 147 Cases of Cavernous Carotid Aneurysms: A Single-Center Experience

机译:147例海绵状颈动脉瘤的血管内治疗:单中心经验

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Cavernous carotid aneurysms (CCAs) are characterized by pain and neuro-ophthalmologic deficits. The optimal treatment remains unclear, especially for asymptomatic CCAs. This study investigated the efficacy of endovascular treatment for CCAs in our center. Methods: Data obtained from patients who underwent endovascular treatment for CCAs from July 2011 to July 2014 were reviewed. A retrospective analysis was conducted regarding the general condition, clinical presentation, aneurysm characteristics, therapeutic strategy, and prognosis of CCA patients. Results: One hundred forty-seven patients who exhibited 155 CCAs were included, which comprised 46 asymptomatic and 101 symptomatic CCA cases. Forty-eight cases presented with headache, 5 cases presented with subarachnoid hemorrhage, 20 cases presented with diplopia, 38 cases presented with cranial nerve palsy, and 27 cases presented with ischemic stroke. The mean aneurysm sizes were 15.3 +/- 12.2 and 8.1 +/- 7.1 mm in the symptomatic and asymptomatic groups, respectively. Different treatments were administered: coil occlusion (n = 15), stent/balloon-assisted coil occlusion (n = 123), and parent artery occlusion (PAO) (n = 17). The PAO-treated group exhibited the highest aneurysm occlusion rate. Followup data were available for 131 cases, which included 86 symptomatic and 45 asymptomatic cases. There were no deaths. Among the symptomatic patients, 40.7% improved, 58.1% remained stable, and 1.2% worsened; 12 patients exhibited regrowth and 6 patients had repeated endovascular treatment. The asymptomatic patients remained stable, including 5 patients who exhibited regrowth and 2 patients who had repeated endovascular treatment. Conclusion: Endovascular treatment is safe and effective for CCAs and should be considered in patients with minimal complications, as well as in asymptomatic patients with stable symptoms.
机译:背景:海绵状颈动脉瘤(CCA)的特点是疼痛和神经眼科缺陷。最佳治疗方案尚不清楚,尤其是对于无症状的CCA。这项研究调查了我们中心CCA血管内治疗的疗效。方法:回顾性分析2011年7月至2014年7月接受CCA腔内治疗的患者的数据。对CCA患者的一般情况,临床表现,动脉瘤特征,治疗策略和预后进行了回顾性分析。结果:纳入147例CCA的147例患者,包括46例无症状和101例有症状的CCA病例。头痛48例,蛛网膜下腔出血5例,复视20例,颅神经麻痹38例,缺血性中风27例。有症状组和无症状组的平均动脉瘤大小分别为15.3 +/- 12.2和8.1 +/- 7.1 mm。进行了不同的治疗:线圈闭塞(n = 15),支架/气囊辅助线圈闭塞(n = 123)和父母动脉闭塞(PAO)(n = 17)。 PAO治疗组显示出最高的动脉瘤闭塞率。有131例病例的随访数据,包括86例有症状和45例无症状病例。没有死亡。在症状患者中,改善40.7%,保持稳定的58.1%,恶化的1.2%。 12例患者出现了再生长,6例患者接受了重复血管内治疗。无症状患者保持稳定,包括5例出现再生长的患者和2例反复进行血管内治疗的患者。结论:血管内治疗对于CCA是安全有效的,对于并发症最少的患者以及症状稳定的无症状患者应考虑采用血管内治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号